Changes in antimullerian hormone levels in early pregnancy are associated with preterm birth.

ABSTRACT:

Objective

To determine the association of preterm birth with antimüllerian hormone (AMH) levels both in isolation and in combination with other markers of fetoplacental health commonly measured during integrated prenatal screening (IPS) for aneuploidy.

Design

Retrospective case-control study.

Setting

Not applicable.

Patient(s)

Pregnant women in Iowa who elected to undergo IPS and who subsequently delivered in Iowa, including women giving birth at <37 weeks' gestation and controls who delivered at ≥37 weeks' gestation.

Intervention(s)

None.

Main outcome measure(s)

Probability of a preterm birth.

Result(s)

Second trimester AMH levels were not associated with preterm birth, either independently or after controlling for other markers of fetopla

SUBMITTER: Stegmann BJ 

PROVIDER: S-EPMC5057574 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature